Centessa Pharmaceuticals PLC
F:260
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Centessa Pharmaceuticals PLC
F:260
|
UK |
Multiples-Based Value
The Multiples-Based Value for
Centessa Pharmaceuticals PLC (260) under the Base Case is 0.32 EUR.
Compared with the current market price of 33.6 EUR, the stock appears
Overvalued by 99% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.